Research on phage therapy conducted at the Hirszfeld Institute presented at the National Institutes of Health

On November 12–13, 2026, Prof. Krystyna Dąbrowska, head of our Institute’s Laboratory of Phage Molecular Biology, participated—at the invitation of the organizers—in an international scientific meeting “Advancing Phage Therapy: Collaborative Strategies for Overcoming Scientific and Regulatory Challenges,” organized by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The event took place in Washington, USA.

During the meeting, Prof. Dąbrowska delivered an invited lecture on the immune system’s response to bacteriophages and its significance for the safety and efficacy of phage therapy.

The event brought together experts engaged in research on bacteriophages, their clinical application, and the challenges associated with the development of phage therapy as a method for combating bacterial infections, particularly those caused by antibiotic-resistant bacteria.

The invitation to present the results of research conducted at the Hirszfeld Institute at the NIH is a significant honor and a confirmation of the international importance of the Institute’s research on the interactions between bacteriophages and the human immune system.

More information about the event: https://web.cvent.com/event/4e0b145d-3d17-487d-9bac-37a572e27ba8/summary